Free Republic

AP Science Writer Tiny capsules made from seaweed and iron may help diabetics whose bodies reject insulin-cell transplants. Researchers trying to understand why those transplants work for some people with Type I diabetes, but not for others, found success in experiments with mice and pigs. Type I diabetes is the type usually beginning in childhood. It occurs when a person's immune system destroys the cells in the pancreas that make insulin. The American Diabetic Association estimated that 20.8 million Americans have diabetes, though not all cases have been diagnosed. Between 5 percent and 10 percent of those are Type I,...

Cord Blood Registry® (CBR®), the world’s largest and most experienced cord blood stem cell bank, today announced that it has released a total of five stem cell samples in the first quarter of the year for transplant or infusion. Three of the cases are individuals who will require their own cord blood stem cells for autologous infusions for cerebral palsy, type I diabetes, and a rare autoimmune disorder related to autism. The additional two samples were released for use by a sibling in each family: one to treat acute myeloid leukemia and the other to treat a serious blood disease,...

Although a number of unique diabetes treatments are already in the works, researchers at Johns Hopkins University are giving it a shot of their own with a newfangled intravascular implant. A team of undergrads have collaborated with doctors and biomedical engineers to develop a "specialized implant for a potential treatment of type I diabetes," which has been created for implantation inside the portal vein in order to dole out insulin when needed. The pouch would ideally be "impregnated with insulin-producing pancreatic beta cells," but researchers have insinuated that this same system could possibly be used to treat other ailments such...

uWink to Host Charity Event for Juvenile Diabetes at Grand Opening Celebration for New Restaurant Monday November 13, 1:27 pm ET Special Guests will be Treated to uWink's Unique Combination of Food, Drinks and Digital Media LOS ANGELES--(BUSINESS WIRE)--uWink, Inc. (OTCBB: UWNK - News), a publicly held digital entertainment company, will host a charity Grand Opening event benefiting the Juvenile Diabetes Research Foundation (JDRF) on November 30, 2006. The celebration will be held at uWink's newly opened Woodland Hills location from 6:00pm - 10:00pm. The invitation-only event will offer guests the opportunity to experience uWink's innovative combination of food, drinks...

It’s a Lie, but Is It Fraud? By Reason McLucus Congress should investigate the false claims being made by advocates of embryonic stem cell research, particularly in light of the recent statement by Ronald D.G. McKay of the National Institute of Neurological Disorders and Stroke: “To start with, people need a fairy tale. Maybe that’s unfair, but they need a story line that’s relatively simple to understand.” McKay’s statement implies that embryonic stem cell researchers are deliberately lying about the value of their research in order to take money away from other areas of research that offer more promise for...